Flavonoids - Therapeutic use
Research News and Information

Sunday, November 22, 2009

Correlation between anti-fibrotic effect of baicalin and serum cytokines in rat hepatic fibrosis.

5 Oct 2009 AIM: To investigate the correlation between the antifibrotic effect of baicalin and serum cytokine production in rat hepatic fibrosis. METHODS: Forty male Sprague-Dawley rats were divided randomly into four groups: normal control group, model group, ... Read more...

Effects of consumption of pomegranate juice on carotid intima-media thickness in men and women at moderate risk for coronary heart disease.

29 Sep 2009 This randomized, double-blind, parallel trial assessed the influence of pomegranate juice consumption on anterior and posterior carotid intima-media thickness (CIMT) progression rates in subjects at moderate risk for coronary heart disease. Subjects ... Read more...

Topical polyphenolic antioxidants reduce the adverse effects of intense pulsed light therapy.

30 Aug 2009 BACKGROUND: Intense pulsed light therapy (IPL) has been associated with erythema and increased lipid peroxidation. Polyphenolic antioxidants have been shown to decrease inflammation and reduce oxidative stress in irradiated skin. Objective: To ... Read more...

Latest indexed articles for 'Flavonoids - Therapeutic use'

These are the very latest articles for this heading:

• Correlation between anti-fibrotic effect of baicalin and serum cytokines in rat hepatic fibrosis. 5 Oct 2009
• Effects of consumption of pomegranate juice on carotid intima-media thickness in men and women at moderate risk for coronary heart disease. 29 Sep 2009
• Topical polyphenolic antioxidants reduce the adverse effects of intense pulsed light therapy. 30 Aug 2009
• The potential utility of green tea extract as a novel treatment for cutaneous leishmaniasis. 30 Jul 2009
• Emerging therapies for patients with advanced chronic lymphocytic leukaemia. 27 Jul 2009
• Type 2 diabetes and glycemic response to grapes or grape products. 20 Jul 2009
• Grapes and cardiovascular disease. 20 Jul 2009
• Inhibition of MMP-3 activity and invasion of the MDA-MB-231 human invasive breast carcinoma cell line by bioflavonoids. 18 Jul 2009
• Breviscapine ameliorates hypertrophy of cardiomyocytes induced by high glucose in diabetic rats via the PKC signaling pathway. 11 Jul 2009
• Dark chocolate or tomato extract for prehypertension: a randomised controlled trial. 6 Jul 2009
• Green tea extract: a novel addition to the antihirsutism armamentarium? 29 Jun 2009
• Antihypertensive effects of flavonoids isolated from brazilian green propolis in spontaneously hypertensive rats. 29 Jun 2009
• The role of polar phytocomplexes on anticonvulsant effects of leaf extracts of Lippia alba (Mill.) N.E. Brown chemotypes. 29 Jun 2009
• Preventive effects of oligomerized polyphenol on estradiol-induced prostatitis in rats. 21 Jun 2009
• From orbital hybridization to chemotherapeutics neutralization. 9 Jun 2009
• Polyphenols in the prevention and treatment of sepsis syndromes: rationale and pre-clinical evidence. 5 Jun 2009
• [Metabolism of nitric oxide (NO) and arginine: significance for male health] 31 May 2009
• Neuropharmacological activity of the pericarp of Passiflora edulis flavicarpa degener: putative involvement of C-glycosylflavonoids. 31 May 2009
• Phenolic composition, antioxidant capacity and in vitro cancer cell cytotoxicity of nine prickly pear (Opuntia spp.) juices. 30 May 2009
• The potential and practical applications of acylated flavonoids. 30 May 2009

See a longer list of these articles.

Technical information about 'Flavonoids'

Definition: A group of phenyl benzopyrans named for having structures like FLAVONES.

Registry Number: 0

Descriptor UI: D005419

Alternative terms: Flavonoids; 2-Phenyl-Chromenes; 2 Phenyl Chromenes; 2-Phenyl-Benzopyrans; 2 Phenyl Benzopyrans; Bioflavonoids;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D03.438.150.266.450; D03.830.219.266.450;

History Note: 2004(1963)

Technical Notes: do not confuse with FLAVINS, pigments